Guy Pratt
A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma
Pratt, Guy; Yap, Christina; Oldreive, Ceri; Slade, Daniel; Bishop, Rebecca; Griffiths, Mike; Dyer, Martin J.S.; Fegan, Chris; Oscier, David; Pettitt, Andrew; Matutes, Estella; Devereux, Stephen; Allsup, David; Bloor, Adrian; Hillmen, Peter; Follows, George; Rule, Simon; Moss, Paul; Stankovic, Tatjana
Authors
Christina Yap
Ceri Oldreive
Daniel Slade
Rebecca Bishop
Mike Griffiths
Martin J.S. Dyer
Chris Fegan
David Oscier
Andrew Pettitt
Estella Matutes
Stephen Devereux
Professor David Allsup D.J.Allsup@hull.ac.uk
Professor of Haematology
Adrian Bloor
Peter Hillmen
George Follows
Simon Rule
Paul Moss
Tatjana Stankovic
Citation
Pratt, G., Yap, C., Oldreive, C., Slade, D., Bishop, R., Griffiths, M., Dyer, M. J., Fegan, C., Oscier, D., Pettitt, A., Matutes, E., Devereux, S., Allsup, D., Bloor, A., Hillmen, P., Follows, G., Rule, S., Moss, P., & Stankovic, T. (2018). A multi-centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T-prolymphocytic leukaemia or mantle cell lymphoma. British journal of haematology, 182(3), 429-433. https://doi.org/10.1111/bjh.14793
Journal Article Type | Article |
---|---|
Acceptance Date | May 1, 2017 |
Online Publication Date | Jun 23, 2017 |
Publication Date | 2018-08 |
Deposit Date | Mar 22, 2018 |
Publicly Available Date | Apr 16, 2018 |
Journal | British Journal of Haematology |
Print ISSN | 0007-1048 |
Publisher | Wiley |
Peer Reviewed | Peer Reviewed |
Volume | 182 |
Issue | 3 |
Pages | 429-433 |
DOI | https://doi.org/10.1111/bjh.14793 |
Keywords | Hematology |
Public URL | https://hull-repository.worktribe.com/output/752070 |
Publisher URL | https://onlinelibrary.wiley.com/doi/abs/10.1111/bjh.14793 |
Related Public URLs | https://research.birmingham.ac.uk/portal/en/publications/a-multicentre-phase-i-trial-of-the-parp-inhibitor-olaparib-in-patients-with-relapsed-chronic-lymphocytic-leukaemia-tprolymphocytic-leukaemia-or-mantle-cell-lymphoma(c4e32a7c-b830-4da6-9706-617523100aa4).html |
Contract Date | Mar 22, 2018 |
Files
Article
(165 Kb)
PDF
You might also like
Measurable Residual Disease–Guided Therapy for Chronic Lymphocytic Leukemia
(2025)
Journal Article
Chronic Lymphocytic Leukemia Care and Beyond: Navigating the Needs of Long-Term Survivors
(2025)
Journal Article